Related Experiment Video

Updated: Sep 7, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

470

COVID-19 and Aortic Thrombosis: A Case Report

Mamtha Balla1, Hannah Staats-Ciotola2, Meera Dhavale3

  • 1Department of Internal Medicine, University of Toledo and Promedica Toledo Hospital, Toledo, OH 43606, USA.

Journal of Community Hospital Internal Medicine Perspectives
|June 17, 2022
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause hypercoagulability, leading to blood clots like stroke and aortic thrombus in COVID-19 patients. Monitoring and anticoagulant treatment are crucial for managing this complication.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hematology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, primarily presents with respiratory symptoms.
  • Emerging evidence suggests COVID-19 can also lead to significant hypercoagulability and thromboembolic events.
  • The pandemic has highlighted the need to understand non-respiratory complications of SARS-CoV-2 infection.

Observation:

  • This case report details a COVID-19 patient who experienced a stroke.
  • The patient was also diagnosed with an aortic thrombus, indicating arterial thrombosis.
  • The case underscores the potential for severe vascular complications in COVID-19.

Findings:

  • COVID-19 patients may develop hypercoagulable states, increasing the risk of both venous and arterial thrombosis.
  • Laboratory markers for hypercoagulability and symptoms of thromboembolism warrant close monitoring in infected individuals.
  • Anticoagulant prophylaxis and treatment may be necessary for managing thrombotic complications.

Implications:

  • Physicians should maintain a high index of suspicion for thromboembolic events in COVID-19 patients.
  • Early detection and management of hypercoagulability can potentially prevent severe outcomes.
  • Further research is needed to elucidate the causal relationship between SARS-CoV-2 and hypercoagulability.

Keywords:
Aortic thrombusComplications of COVID-19Covid-19

More Related Videos

Aortic Ring Assay09:12

Aortic Ring Assay

Published on: November 24, 2009

31.4K
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

1.1K

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
51
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
21
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
35
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
39
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
25
Thoracic Aorta01:15

Thoracic Aorta

The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
715